T45 Labs

Thanksgiving reminds us that progress moves in fits, leaps, and moments of alignment that bring together the right people, focused on the right problems, at the right time. At T45 Labs, we’re grateful for these moments of alignment. For the clinicians who see what others miss. For the engineers who turn ideas into working prototypes. For the investors who place their trust in the data and the possibility of better care. And for a team that shows up every day, determined to push cardiovascular innovation one step closer to the patients who need it. Thank you all for being part of this trajectory. Happy Thanksgiving! #Thanksgiving #Gratitude #Medtech #HealthcareInnovation #T45Labs #team #cardiology #cardiovascular

We welcome Kendall Christmas-Miller to T45 Labs as our Finance and Accounting Manager. Kendall brings over a decade of experience spanning financial reporting, audit coordination, and process improvement. With expertise in accounting operations, budgeting, and forecasting, Kendall will oversee financial operations and reporting as we continue to scale. Welcome to the team, Kendall!

We’re pleased to welcome Monique Harris to the team at T45 Labs! Monique brings over two decades of experience in clinical research, with a deep understanding of clinical operations and cardiovascular trials. She’s led efforts across medtech and pharma settings, and we’re lucky to have her perspective and steady hand on board. She joins us as a Senior Clinical Research Associate, helping shape and support our growing clinical programs. Welcome, Monique! #T45Labs #ClinicalResearch #MedTech #Cardiology #Innovation #welcome #team

Coronary microvascular dysfunction (CMD) has long gone underdiagnosed, under-treated, and underestimated. At #TCT2025, our portfolio company VahatiCor Inc is hosting a spotlight symposium to explore how coronary sinus reducer therapy could support a new treatment path for patients with CMD. It’s a timely conversation about a condition that has gone unseen for too long. Sunday, October 26 | 12:30–1:30 PM (PDT) Scientific Abstract Station 1, Innovation & Training Hall (Hall D), Moscone South, San Francisco Save the date to your calendar: https://evt.to/eoioogahw We're looking forward to hearing from Amir Lerman, Bruce Samuels, Alexandra Lansky, Samit Shah MD, PhD, Francesco Giannini, Odayme Quesada, MD, MHS, FACC, FAHA, FESC, and Khaled Ziada as they lead this essential discussion. #VahatiCor #T45Labs #interventionalcardiology #MicroisHuge #NowWeSeeYou #TCT2025 #CMD #Cardiology #MedicalInnovation

Sometimes the biggest innovation isn’t adding more. It is removing what gets in the way. We designed NuevoSono to remove friction from intravascular imaging.  Our updated website tells that story: https://nuevosono.com/ 

New look. Same focus. The updated T45 Labs website is now live: https://t45labs.com/ Marwan Berrada-Sounni Sanj Kalra Michael Mandel

Every great playbook needs a world-class leader of the field. We’re proud to name Dr. Rishi Puri, M.D., Ph.D., F.R.A.C.P. as Chief Medical Director at T45 Labs. A world-renowned interventional cardiologist, researcher, clinical trialist, and medical device innovator, Dr. Puri brings unmatched expertise in device development across coronary, structural heart, and interventional heart failure domains. With over 450 peer-reviewed publications to-date along with regular appearances on global podiums, Dr. Puri remains a driving voice in cardiovascular innovation. He will continue to work as a full-time Coronary and Structural Interventional Cardiologist at the Cleveland Clinic, and serve as an Adjunct Professor at Swinburne University of Technology, in Melbourne, Australia. Dr. Puri is both an academic and industry champion. He brings a rare breadth of expertise and accomplishments across cardiac device innovation, mechanistic research and its translation, first-in-man procedures, through to leading pivotal trials. His clinical and research career thus far spans two hemispheres and three continents, establishing him as a truly influential presence at the forefront of cardiovascular care. Please join us in welcoming Dr. Rishi Puri to T45 Labs. We are lucky to have him, and even luckier that his clarity and clinical rigor will now help shape the future of our expanding Cardiovascular Medtech device portfolio. Marwan Berrada-Sounni #T45Labs #Cardiology #MedicalInnovation #Leadership #MedTech #InterventionalCardiology

We’re excited to welcome Jeff Umscheid, SHRM-CP, CEC to T45 Labs as Senior Director of HR & Operational Strategy. Jeff brings a thoughtful, execution-focused approach to supporting growth-stage companies and building resilient teams. His experience across HR, operations, and business planning will be a key asset as we continue scaling the T45 platform. Welcome aboard, Jeff. #T45Labs #TeamGrowth #MedTechLeadership

The Founding Fathers bet on a startup called America. No blueprint. No guarantee. Just belief, grit, and timing. At T45 Labs, we like that energy. This 4th of July, we’re raising a glass to unreasonable optimism and the founders who keep betting on better. #FourthOfJuly #IndependenceDay #Medtech #Innovation #T45Labs

We’re excited to welcome Sara Royce as our new Director of Regulatory at T45 Labs. Sara brings nearly a decade of regulatory experience from the FDA, where she most recently served as Assistant Director of the Implantable Electrophysiology Devices Team. Her previous roles included Team Lead for Plaque Modification Devices and Lead Reviewer for interventional technologies. With a Ph.D. in Biomedical Engineering from Yale and a B.S. from Carnegie Mellon, Sara combines deep technical expertise with proven leadership in regulatory strategy. At T45 Labs, Sara will lead regulatory planning across our portfolio, helping bring novel cardiovascular technologies from development to clearance. Welcome aboard, Sara! We're thrilled to have you on this journey with us.